Zymeworks

2 followers


Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.

Industries

Headquarters

Stage

Employees

Links

Kenneth Galbraith

Collapse
Chris Astle
SVP & CFO
Kathryn O’Driscoll
Chief People Officer
Paul Moore
Chief Scientific Officer
Daniel Dex
SVP, Corporate Secretary & General Counsel
Mark Hollywood
SVP, Technical & Manufacturing Operations
Jeffrey Smith
EVP & Chief Medical Officer
John Fann
SVP, Process Sciences
Barbara Schaeffler
VP, Clinical Development Operations
Lucas Donigian
VP, Business & Commercial Development
Bijal Desai
VP, Finance & Strategy
Cathie Graham
VP, Legal
Raquera Brown
VP, Quality
Laura O’Connor
VP, Human Resources & DEI
Lindsey Foulkes
VP, Corporate Development
Josemund Menezes
MD, Early-Stage Development, Asia Pacific
Franchesca Nguyen Mph
Director, Program And Alliance Management
Lin Yang
Associate Director Biostatistics
Jamie Rich
Senior Director, Technology | ADC Therapeutic Development
Thomas Spreter von Kreudenstein
Director, Protein Engineering
Will Benjamin
Senior Director, Information Technology
Kurt Stahl
Senior Scientist, Toxicology
Peter Repenning
Associate Scientist, Multispecific Antibody Therapeutics
Wingkie Wong
Senior Research Associate